SCHEMBL23160938

SCHEMBL23160938

CCc1cc(=O)nc(-n2nc(C)cc2NCc2cccc(C)c2)[nH]1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADCY1 Q08828 15/20 0.54
▸ ADCY8 P40145 12/20 0.48
▸ HTR2B P41595 3/20 0.48
▸ KDM4E B2RXH2 1/20 0.43
▸ S1PR4 O95977 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ TP53 P04637 1/20 0.43
▸ ALPL P05186 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ SLC2A1 P11166 1/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ S1PR1 P21453 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ AGTR1 P30556 1/20 0.43
▸ OPRK1 P41145 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ KCNN3 Q9UGI6 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25349065 0.86 ADCY1 (0.74) ADCY1ADCY8HTR2BALDH1A1SLC2A1
SCHEMBL23188259 0.83 ADCY1 (0.75) ADCY1ADCY8HTR2B
SCHEMBL25986173 0.82 SLC2A1 (0.61) ADCY1ADCY8HTR2BKDM4ES1PR4
SCHEMBL23160933 0.82 ADCY1 (0.73) ADCY1ADCY8HTR2B
SCHEMBL23160928 0.81 ADCY1 (0.56) ADCY1ADCY8HTR2BKDM4ES1PR4
SCHEMBL23160950 0.79 ADCY1 (0.73) ADCY1ADCY8HTR2B
SCHEMBL25986182 0.78 TP53 (0.54) ADCY1ADCY8HTR2BTP53MAPT
SCHEMBL25986184 0.77 ADCY1 (0.52) ADCY1ADCY8HTR2BKDM4ES1PR4
SCHEMBL23160929 0.77 ADCY1 (0.73) ADCY1ADCY8HTR2B
SCHEMBL23160940 0.77 ADCY8 (0.68) ADCY1ADCY8HTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12414949-B2 Pyrazolyl pyrimidinone compounds and the uses thereof PURDUE RESEARCH FOUNDATION (US) 2025-09-16 — — US disclosed
US-20230293523-A1 PYRAZOLYL PYRIMIDINONE COMPOUNDS AND THE USES THEREOF PURDUE RESEARCH FOUNDATION (US) 2023-09-21 — — US disclosed
US-20230250084-A1 PYRAZOLYL PYRIMIDINONE COMPOUNDS AND THE USES THEREOF PURDUE RESEARCH FOUNDATION (US) 2023-08-10 — — US disclosed
US-11690844-B2 Pyrazolyl pyrimidinone compounds and the uses thereof PURDUE RESEARCH FOUNDATION (US) 2023-07-04 — — US disclosed
US-20210100797-A1 PYRAZOLYL PYRIMIDINONE COMPOUNDS AND THE USES THEREOF PURDUE RESEARCH FOUNDATION (US) 2021-04-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12414949-B2 Pyrazolyl pyrimidinone compounds and the uses thereof CAP1, ADCY1, ADCYAP1R1 ADCY1 2/4885ADCY8 9/4885HTR2B 1487/4885
US-11690844-B2 Pyrazolyl pyrimidinone compounds and the uses thereof CAP1, ADCY1, ADCYAP1R1 ADCY1 2/4885ADCY8 9/4885HTR2B 1487/4885
US-20230250084-A1 PYRAZOLYL PYRIMIDINONE COMPOUNDS AND THE USES THEREOF CAP1, ADCY1, ADCYAP1R1 ADCY1 2/4885ADCY8 9/4885HTR2B 1487/4885
US-20230293523-A1 PYRAZOLYL PYRIMIDINONE COMPOUNDS AND THE USES THEREOF CAP1, ADCY1, ADCYAP1R1 ADCY1 2/4885ADCY8 9/4885HTR2B 1487/4885
US-20210100797-A1 PYRAZOLYL PYRIMIDINONE COMPOUNDS AND THE USES THEREOF CAP1, ADCY1, ADCYAP1R1 ADCY1 2/4885ADCY8 9/4885HTR2B 1487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback